Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase
Clinical trial NCT01872442 · COMPLETED
Trial details
- NCT number
- NCT01872442
- Sponsor
- Poitiers University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-15
- Primary completion
- 2018-10-31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.